By REBECCA DYER Researchers have discovered how a cell surface protein called Aplp1 can play a role in spreading material responsible for Parkinson’s disease from cell-to-cell in the brain. Promisingly, an FDA-approved cancer drug that targets another protein called Lag3 – which interacts with Aplp1 – blocks the spread in mice, suggesting a potential therapy…
This content is for 3 Months, 6 Months, and 12 Months members only.
Join Now
Join Now
Already a member? Log in here
